Significant variation found in timing and selection of genetic tests for non-small-cell lung cancer
Extent of COVID-19 vaccine waste remains largely unknown
15 March 2021Lab studies of emotion and well-being may be missing real-world anxiety
15 March 2021Significant variation found in timing and selection of genetic tests for non-small-cell lung cancer
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC). In a new study in The Journal of Molecular Diagnosis, investigators provide for the first time a complete overview of biomarker testing, spanning multiple treatment lines, in a single cohort of patients.
